다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Cancer biology & therapy, v.13 no.7, 2012년, pp.504 - 515
Kim, Jae-Won , Jung, Seok-Yun , Kwon, Yi-Hong , Lee, Jun-Hee , Lee, You Mie , Lee, Boo-Yong , Kwon, Sang-Mo
AI-Helper
Accumulating evidence suggests that Ginsenoside Rg3 appears to inhibit tumor growth including Lewis lung carcinoma, intestinal adenocarcinomas or B16 melanoma by inhibiting cell proliferation, tumor cell invasion and metastasis. Endothelial progenitor cells (EPCs) appear to play a key role in the gr...
Cooney, Matthew M, van Heeckeren, Willem, Bhakta, Shyam, Ortiz, Jose, Remick, Scot C. Drug Insight: vascular disrupting agents and angiogenesis-novel approaches for drug delivery. Nature clinical practice. Oncology, vol.3, no.12, 682-692.
Bergers, Gabriele, Benjamin, Laura E.. Angiogenesis: Tumorigenesis and the angiogenic switch. Nature reviews. Cancer, vol.3, no.6, 401-410.
Skowasch, Dirk, Jabs, Alexander, Lüderitz, Berndt, Bauriedel, Gerhard. Bone Marrow-Derived Cells and Vascular Growth. Circulation research : a journal of the American Heart Association, vol.94, no.8,
Du, Rose, Lu, Kan V., Petritsch, Claudia, Liu, Patty, Ganss, Ruth, Passegué, Emmanuelle, Song, Hanqiu, VandenBerg, Scott, Johnson, Randall S., Werb, Zena, Bergers, Gabriele. HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion. Cancer cell, vol.13, no.3, 206-220.
Zheng, Hao, Fu, Guosheng, Dai, Tao, Huang, He. Migration of Endothelial Progenitor Cells Mediated by Stromal Cell-Derived Factor-1α/CXCR4 via PI3K/Akt/eNOS Signal Transduction Pathway. Journal of cardiovascular pharmacology, vol.50, no.3, 274-280.
Shojaei, Farbod, Wu, Xiumin, Qu, Xueping, Kowanetz, Marcin, Yu, Lanlan, Tan, Martha, Meng, Y. Gloria, Ferrara, Napoleone. G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proceedings of the National Academy of Sciences of the United States of America, vol.106, no.16, 6742-6747.
Lyden, David, Hattori, Koichi, Dias, Sergio, Costa, Carla, Blaikie, Pamela, Butros, Linda, Chadburn, Amy, Heissig, Beate, Marks, Willy, Witte, Larry, Wu, Yan, Hicklin, Daniel, Zhu, Zhenping, Hackett, Neil R., Crystal, Ronald G., Moore, Malcolm A.S., Hajjar, Katherine A., Manova, Katia, Benezra, Robert, Rafii, Shahin. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature medicine, vol.7, no.11, 1194-1201.
Nolan, Daniel J., Ciarrocchi, Alessia, Mellick, Albert S., Jaggi, Jaspreet S., Bambino, Kathryn, Gupta, Sunita, Heikamp, Emily, McDevitt, Michael R., Scheinberg, David A., Benezra, Robert, Mittal, Vivek. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes & development, vol.21, no.12, 1546-1558.
Gao, Dingcheng, Nolan, Daniel J., Mellick, Albert S., Bambino, Kathryn, McDonnell, Kevin, Mittal, Vivek. Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis. Science, vol.319, no.5860, 195-198.
Kopp, Hans-Georg, Ramos, Carlos A, Rafii, Shahin. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Current opinion in hematology, vol.13, no.3, 175-181.
Asahara, Takayuki, Takahashi, Tomono, Masuda, Haruchika, Kalka, Christoph, Chen, Donghui, Iwaguro, Hideki, Inai, Yoko, Silver, Marcy, Isner, Jeffrey M.. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. The EMBO journal, vol.18, no.14, 3964-3972.
Gasparini, Giampietro, Longo, Raffaele, Toi, Masakazu, Ferrara, Napoleone. Angiogenic inhibitors: a new therapeutic strategy in oncology. Nature clinical practice. Oncology, vol.2, no.11, 562-577.
Kerr, David J. Targeting angiogenesis in cancer: clinical development of bevacizumab. Nature clinical practice. Oncology, vol.1, no.1, 39-43.
Perabo, F G E, Von Löw, E C, Ellinger, J, von Rücker, A, Müller, S C, Bastian, P J. Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate cancer and prostatic diseases, vol.11, no.1, 6-12.
Wong, Vincent Kam Wai, Cheung, Simon Shiu Fai, Li, Ting, Jiang, Zhi‐Hong, Wang, Jing‐Rong, Dong, Hang, Yi, Xiao Qin, Zhou, Hua, Liu, Liang. Asian ginseng extract inhibits in vitro and in vivo growth of mouse lewis lung carcinoma via modulation of ERK‐p53 and NF‐κB signaling. Journal of cellular biochemistry, vol.111, no.4, 899-910.
J Korean Med Sci Surh YJ S38 16 2001 10.3346/jkms.2001.16.S.S38
Chang-Xiao, L., Pei-Gen, X.. Recent advances on ginseng research in China. Journal of ethnopharmacology, vol.36, no.1, 27-38.
Zhang, Qingyuan, Kang, Xinmei, Zhao, Weihui. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma. Biochemical and biophysical research communications, vol.342, no.3, 824-828.
Zhongguo Zhong Xi Yi Jie He Za Zhi Yi C 58 25 2005
Iishi, Hiroyasu, Tatsuta, Masaharu, Baba, Miyako, Uehara, Hiroyuki, Nakaizumi, Akihiko, Shinkai, Kiyoko, Akedo, Hitoshi, Funai, Hiroko, Ishiguro, Shingo, Kitagawa, Isao. Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clinical & experimental metastasis, vol.15, no.6, 603-611.
Zhonghua Zhong Liu Za Zhi Liu JW 722 26 2004
Nagy, J A, Chang, S-H, Dvorak, A M, Dvorak, H F. Why are tumour blood vessels abnormal and why is it important to know?. The British journal of cancer, vol.100, no.6, 865-869.
Recent Prog Horm Res Ferrara N. 15 55 2000
Ivy, S. Percy, Wick, Jeannette Y., Kaufman, Bennett M.. An overview of small-molecule inhibitors of VEGFR signaling. Nature reviews. Clinical oncology, vol.6, no.10, 569-579.
Grothey, Axel, Galanis, Evanthia. Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nature reviews. Clinical oncology, vol.6, no.9, 507-518.
10.1161/hc0602.103673
Shaked, Yuval, Ciarrocchi, Alessia, Franco, Marcela, Lee, Christina R., Man, Shan, Cheung, Alison M., Hicklin, Daniel J., Chaplin, David, Stuart Foster, F., Benezra, Robert, Kerbel, Robert S.. Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors. Science, vol.313, no.5794, 1785-1787.
10.4161/cc.5.5.2538
Murphy, D.A., Makonnen, S., Lassoued, W., Feldman, M.D., Carter, C., Lee, W.M.F.. Inhibition of Tumor Endothelial ERK Activation, Angiogenesis, and Tumor Growth by Sorafenib (BAY43-9006). The American journal of pathology, vol.169, no.5, 1875-1885.
Fang, Jing, Zhou, Qiong, Liu, Ling-Zhi, Xia, Chang, Hu, Xiaowen, Shi, Xianglin, Jiang, Bing-Hua. Apigenin inhibits tumor angiogenesis through decreasing HIF-1α and VEGF expression. Carcinogenesis, vol.28, no.4, 858-864.
Yi, Tingfang, Cho, Sung-Gook, Yi, Zhengfang, Pang, Xiufeng, Rodriguez, Melissa, Wang, Ying, Sethi, Gautam, Aggarwal, Bharat B., Liu, Mingyao. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Molecular cancer therapeutics, vol.7, no.7, 1789-1796.
DVORAK, H. F.. Angiogenesis: update 2005. Journal of thrombosis and haemostasis : JTH, vol.3, no.8, 1835-1842.
Circ Res Asahara T 477 85 1999 10.1161/01.RES.85.3.221
Oh, Ho-Kyun, Ha, Jung-Min, O, Eunju, Lee, Byung Hun, Lee, Suk Keun, Shim, Byoung-Shik, Hong, Yong-Kil, Joe, Young Ae. Tumor Angiogenesis Promoted by Ex vivo Differentiated Endothelial Progenitor Cells Is Effectively Inhibited by an Angiogenesis Inhibitor, TK1-2. Cancer research : the official organ of the American Association for Cancer Research, Inc, vol.67, no.10, 4851-4859.
Kerbel, Robert S.. Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer?. Science, vol.312, no.5777, 1171-1175.
10.1007/3-7643-7311-3_10
Mol Cell Biol Ohtsubo M 2612 15 1995 10.1128/MCB.15.5.2612
10.1073/pnas.94.20.10699
Mol Cell Biol Lundberg AS 753 18 1998 10.1128/MCB.18.2.753
Guo, Jian, Schally, Andrew V, Zarandi, Marta, Varga, Jozsef, Leung, Peter CK. Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway. Reproductive biology and endocrinology : RB&E, vol.8, 54-54.
Yue, Patrick Y.K., Wong, Daisy Y.L., Ha, W.Y., Fung, M.C., Mak, N.K., Yeung, H.W., Leung, H.W., Chan, Kelvin, Liu, L., Fan, T.P.D., Wong, Ricky N.S.. Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg1 in vivo and in vitro. Angiogenesis, vol.8, no.3, 205-216.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.